HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 95/3/953    most recent 00173.2003v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Buckwalter, J. B. Articles by Clifford, P. S. Search for Related Content PubMed PubMed Citation Articles by Buckwalter, J. B. Articles by Clifford, P. S.

Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors?

Departments of Anesthesiology and Physiology, Medical College of Wisconsin and Veterans Affairs Medical Center, Milwaukee, Wisconsin 53295

Submitted 19 February 2003 ; accepted in final form 19 May 2003

There is evidence that ATP acts as a neurotransmitter in vascular smooth muscle and is coreleased with norepinephrine from sympathetic nerves. We hypothesized that P2X-receptor stimulation with the selective P2X-receptor agonist ,-methylene ATP would produce vasoconstriction in resting and exercising skeletal muscle. Six mongrel dogs were instrumented chronically with flow probes on the external iliac arteries of both hindlimbs and a catheter in one femoral artery. The selective P2X agonist ,-methylene ATP was infused as a bolus into the femoral artery catheter at rest and during mild, moderate, and heavy exercise. Intra-arterial infusions of ,-methylene ATP elicited reductions in vascular conductance of 54 ± 5, 49 ± 8, 39 ± 8, and 30 ± 6% at rest, 3 miles/h, 6 miles/h, and 6 miles/h at a 10% grade, respectively. The agonist infusions did not affect blood flow in the contralateral iliac artery. To examine whether nitric oxide is responsible for the attenuated vasoconstrictor response to P2X stimulation, the infusions were repeated in the presence of N^G-nitro-L-arginine methyl ester. After nitric oxide synthase blockade, intra-arterial infusions of ,-methylene ATP elicited reductions in vascular conductance of 56 ± 7, 61 ± 8, 52 ± 9, and 40 ± 7% at rest, 3 miles/h, 6 miles/h, and 6 miles/h at a 10% grade, respectively. P2X-receptor responsiveness was attenuated during exercise compared with rest. Blockade of nitric oxide production did not affect the attenuation of P2X-receptor responsiveness during exercise. These data support the hypothesis that P2X purinergic receptors can produce vasoconstriction in exercising skeletal muscle.

blood flow; sympatholysis; autonomic nervous system; dogs

This article has been cited by other articles:

				A. E. Kindig, S. G. Hayes, and M. P. Kaufman Purinergic 2 receptor blockade prevents the responses of group IV afferents to post-contraction circulatory occlusion J. Physiol., January 1, 2007; 578(1): 301 - 308. [Abstract] [Full Text] [PDF]

				R. M. Brothers, M. L. Haslund, D. W. Wray, P. B. Raven, and M. Sander Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle J. Physiol., December 1, 2006; 577(2): 727 - 737. [Abstract] [Full Text] [PDF]

				J. B. Buckwalter, J. J. Hamann, and P. S. Clifford Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles J Appl Physiol, December 1, 2005; 99(6): 2115 - 2120. [Abstract] [Full Text] [PDF]

				H. A. Kluess, J. B. Buckwalter, J. J. Hamann, and P. S. Clifford Elevated temperature decreases sensitivity of P2X purinergic receptors in skeletal muscle arteries J Appl Physiol, September 1, 2005; 99(3): 995 - 998. [Abstract] [Full Text] [PDF]

				H. A. Kluess, J. B. Buckwalter, J. J. Hamann, and P. S. Clifford Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H129 - H132. [Abstract] [Full Text] [PDF]

				G. D. Thomas and S. S. Segal Neural control of muscle blood flow during exercise J Appl Physiol, August 1, 2004; 97(2): 731 - 738. [Abstract] [Full Text] [PDF]

				J. B. Buckwalter, J. J. Hamann, H. A. Kluess, and P. S. Clifford Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y? Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H144 - H149. [Abstract] [Full Text] [PDF]

				J. B. Rosenmeier, J. Hansen, and J. Gonzalez-Alonso Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle J. Physiol., July 1, 2004; 558(1): 351 - 365. [Abstract] [Full Text] [PDF]

				J. B. Buckwalter, J. C. Taylor, J. J. Hamann, and P. S. Clifford Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise? Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H633 - H639. [Abstract] [Full Text] [PDF]